Robotic surgery: new robots and finally some real competition!

Area of Science:

• Minimally Invasive Surgery
• Surgical Robotics
• Medical Technology

Background:

• The Da Vinci system has been the sole robotic platform for laparoscopic surgery for two decades.
• This market dominance has resulted in increased costs and limited innovation in the field.
• The emergence of new robotic systems signals a shift in surgical technology.

Purpose of the Study:

• To review two newly approved robotic systems for laparoscopic surgery: the Senhance Surgical Robotic System and the REVO-I Robot Platform.
• To compare these new systems with the established Da Vinci system.
• To discuss the current landscape and future direction of robotic assistance in surgery.

Main Methods:

• Descriptive analysis of the Senhance Surgical Robotic System.
• Descriptive analysis of the REVO-I Robot Platform.
• Comparative discussion of the three robotic systems (Da Vinci, Senhance, REVO-I).

Main Results:

• The Senhance and REVO-I systems offer alternatives to the Da Vinci robot.
• Key differences, pros, and cons of each system are highlighted.
• The review provides insights into the competitive landscape of surgical robotics.

Conclusions:

• New robotic platforms are entering the market, challenging the established monopoly.
• These advancements have the potential to drive innovation and manage costs in robotic surgery.
• The field of robotic-assisted surgery is evolving with new technological options.